pipette
ENEnglish

Continuous directed evolution using engineered human B cell lines

Stanley Bram, Diego J. Orea, Graeme Lindsey, Soyu Zi, Jordan Quenneville, Hui Xu, Sarah Leach, Jenna J. Guthmiller, Angad P. Mehta

Revista con revisión por paresAfirmaciones fuertes, leer con cuidadoUso en el mundo real

En palabras de los autores

Abstract The B cells of the human immune system have evolved somatic hypermutation (SHM) mechanisms that introduce mutations at the immunoglobulin genomic loci at a significantly higher frequency than the rest of the genome thereby allowing them to evolve antibody sequences without compromising fitness due to genome-wide mutations. Inspired by these observations, here we develop a continuous directed evolution platform in human B cell lines (CODE-HB) that repurposes the SHM mechanisms to a stable, non-immunoglobulin genomic locus of the human B cell lines to continuously evolve cytosolic and surface displayed proteins with a broad mutational spectrum comprising of substitutions, deletions and insertions. Using our human B cell surface display platform and CODE-HB, we evolve neutralizing antibodies targeting avian influenza and escape variants of influenza. Given the modularity and simplicity of CODE-HB, we anticipate that this platform can be used for rapidly evolving biotechnologically relevant biomolecules directly in human cells.

Resultado principalEl resumen no menciona limitaciones.

Apareció: domingo, 8 de noviembre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-79127-y